562 related articles for article (PubMed ID: 25802229)
21. CXCR6
Aviles-Padilla K; Angelo LS; Fan D; Paust S
Front Immunol; 2022; 13():886835. PubMed ID: 35844621
[TBL] [Abstract][Full Text] [Related]
22. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
23. NKG2C
Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
[TBL] [Abstract][Full Text] [Related]
24. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
25. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
[TBL] [Abstract][Full Text] [Related]
26. Early Cytomegalovirus Reactivation and Expansion of CD56
Jang JE; Hwang DY; Chung H; Kim SJ; Eom JI; Jeung HK; Song J; Kim JS; Cheong JW; Min YH
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2070-2078. PubMed ID: 31212079
[TBL] [Abstract][Full Text] [Related]
27. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; Barón AE; Weinberg A
Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
[TBL] [Abstract][Full Text] [Related]
28. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
29. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
Tormo N; Solano C; de la Cámara R; Garcia-Noblejas A; Cardeñoso L; Clari MA; Nieto J; López J; Hernández-Boluda JC; Remigia MJ; Benet I; Navarro D
Biol Blood Marrow Transplant; 2010 May; 16(5):653-61. PubMed ID: 20005968
[TBL] [Abstract][Full Text] [Related]
30. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells.
Djaoud Z; David G; Bressollette C; Willem C; Rettman P; Gagne K; Legrand N; Mehlal S; Cesbron A; Imbert-Marcille BM; Retière C
J Immunol; 2013 Sep; 191(5):2708-16. PubMed ID: 23918974
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
Fleming T; Dunne J; Crowley B
J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
[TBL] [Abstract][Full Text] [Related]
32. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
[TBL] [Abstract][Full Text] [Related]
33. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients.
Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P
Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095
[TBL] [Abstract][Full Text] [Related]
34. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.
Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301
[TBL] [Abstract][Full Text] [Related]
35. Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1
Makwana NB; Foley B; Lee S; Fernandez S; Irish AB; Price P
Eur J Immunol; 2016 Nov; 46(11):2597-2608. PubMed ID: 27562679
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Evolution of the Adaptive NKG2C
Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855
[TBL] [Abstract][Full Text] [Related]
37. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS
J Immunol; 2012 Nov; 189(10):5082-8. PubMed ID: 23077239
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies.
Muñoz-Cobo B; Solano C; Costa E; Bravo D; Clari MÁ; Benet I; Remigia MJ; Montoro J; Navarro D
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1602-11. PubMed ID: 21871245
[TBL] [Abstract][Full Text] [Related]
39. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
[TBL] [Abstract][Full Text] [Related]
40. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.
Cichocki F; Cooley S; Davis Z; DeFor TE; Schlums H; Zhang B; Brunstein CG; Blazar BR; Wagner J; Diamond DJ; Verneris MR; Bryceson YT; Weisdorf DJ; Miller JS
Leukemia; 2016 Feb; 30(2):456-63. PubMed ID: 26416461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
